A randomized, placebo-controlled trial of varenicline, a selective alpha4ß2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.

Autor: Tsai S (AUTHOR), Cho H (AUTHOR), Cheng H (AUTHOR), Kim C (AUTHOR), Hsueh K (AUTHOR), Billing CB Jr. (AUTHOR), Williams KE (AUTHOR)
Zdroj: Clinical Therapeutics. Jun2007, Vol. 29 Issue 6, p1027-1039. 13p.
Databáze: Academic Search Ultimate
Externí odkaz: